Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001558370-18-001682
Filing Date
2018-03-08
Accepted
2018-03-08 09:08:47
Documents
4
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A bivv-20171231x10ka.htm 10-K/A 1064106
2 EX-31.3 bivv-20171231ex313a593c3.htm EX-31.3 6111
3 EX-31.4 bivv-20171231ex314ef6f5a.htm EX-31.4 6762
4 GRAPHIC bivv20171231x10ka001.jpg GRAPHIC 9867
  Complete submission text file 0001558370-18-001682.txt   1091686
Mailing Address 225 2ND AVENUE WALTHAM MA 02451
Business Address 225 2ND AVENUE WALTHAM MA 02451 781-663-4400
Bioverativ Inc. (Filer) CIK: 0001681689 (see all company filings)

EIN.: 813461310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37859 | Film No.: 18675219
SIC: 2834 Pharmaceutical Preparations